Pharma and CRO executives have said that CROs could do more to be proactive in their partnerships, though some CRO executives believe that can be difficult because of the varying nature of their clients.
The Association of Clinical Research Organizations (ACRO) has joined a small business coalition as part of its effort to halt the decline of capital into biomedical research.
Supplementing prospective randomized, double-blinded clinical trial data with real-world patient data holds “an enormous amount of potential” for CROs and trial sponsors, according to an expert.
US House Democrats have re-introduced a bill that would expand trial data reported by companies to clinicaltrials.gov, but a recent EU court decision shows what kind of resistance should be expected.
Although preclinical work for CROs has fallen flat in recent quarters, Covance is looking to take advantage of the industry’s shift to early biologic developments and lead optimization.
CRO Harlan Laboratories has more than doubled the number of isolators at its Indianapolis and Livermore, Calif., research facilities to meet client demand for immunocompromised animal models.
US CRO PRA is proposing to go public again, more than six years since it was taken private, according to a confidential draft registration statement submitted to the US SEC.
Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono.
PRA International says technology and IT innovation will help it compete with rivals that have moved their service centres to cheaper locations in the East to cut costs.
Evotec says it is confident underlying growth, expansion of its clinical stage pipeline and upcoming milestone payments will counter Q1’s downcast results.
Research Pharmaceutical Services' (RPS) former chief information officer (CIO) claims he was unfairly dismissed after discovering the CRO was unlawfully storing potential employees' personal data.
Tension between clinical trial sponsors and CROs in terms of CRO oversight may not be relieved any time soon, but both sides seem intent on arriving at a middle ground where micromanagement stays low and the level of quality remains high.
With a more than 27 percent increase in revenue for Q3 of FY 2013 over the same quarter last year, CRO Parexel has raised its guidance for both the fiscal and calendar year.
Covance’s 10 percent growth in Q1 2013 compared to the same quarter last year was driven mostly by its central laboratories business and has caused a boost in its revenue targets for the rest of the year.
Following the completion of remediation efforts to deal with an FDA warning letter, Chris Phillips, AMRI's senior director of its Burlington, Massachusetts site, discusses what he considers to be a "new bar" in enforcement activity from...
With a ruling that could have implications for any CRO looking to understand its rights under a MSA (master services agreement) with a sponsor, a federal district court in Ohio has ruled against CRO Medpace.
CRO Quintiles and its shareholders are offering more than 19 million shares of common stock that will be priced between $36 and $40 per share, according to an updated S-1 filing with the US SEC.
Icon’s first quarter FY2013 revenue increased 26% year on year, besting analysts’ expectations and resulting in a nearly 7% increase in the company’s stock price.
The Kansas Bioscience Authority has awarded a $400,000 grant to the CRO PRA to create a new program to attract recent college graduates into the clinical research and CRO industries.
Despite a downturn in the number of clinical trials across all phases, CROs may still see a substantial increase in bookings as large pharma and biotech companies look to keep costs down, according to an analyst.
Draft revisions to the Declaration of Helsinki (DoH) clarify how placebos should be used and add a general principle for adequate compensation to injured trial participants according to the WMA.
Eisai has tasked a new exec with making trials more likely to succeed just a few months after its candidate ovarian cancer blockbuster failed at Phase III.
An EMA report says increased Russian participation in European submitted clinical trials is part of a trend away from traditional regions, yet fluctuating legislation may affect numbers.
Bristol-Myers Squibb (B-MS) has signed up Quintiles as a central labs supplier, prompting more questions about Icon’s status as a preferred provider of laboratory services.
CRO Ergomed will pay part of the cost of a Phase III trial of Aeterna Zentaris’ candidate endometrial cancer treatment in exchange for a share of future profits.
Private equity firm Water Street has invested an undisclosed sum in clinical trial services group CCBR-Synarc citing opportunities in the patient recruitment and image analysis markets as the key driver for the move.
Novartis, the J. Craig Venter Institute, Synthetic Genomics Vaccines and the US CDC are racing to develop a vaccine for the H7N9 influenza virus sweeping through China.
J. Knipper and Co. claims the acquisition of InVentiv Health’s sample management and fulfillment business makes it the largest manufacturer-to-physician drug sample services firm in the US.
Opinion is polarised as debate rages over the issue of dual enrolment in clinical trials, with ACRO claiming occurrence is "rare" whilst industry takes action to counter the “widespread issue.”
RPS (ReSearch Pharmaceutical Services Inc.) says its JV with Asklep will provide more options for big pharma and biologic companies looking to outsource Japanese or pan-Asian clinical trials.
US Researchers say a new site MyClinicalTrialLocator.com gives patients a simple way of finding clinical trials and may aid sponsor and CRO recruitment efforts.
Concern over controversial new Indian rules on trial participant compensation for study-related injuries is likely to spark changes that may be difficult and time consuming to implement, according to industry sources.
B-MS' (Bristol-Myers Squibb's) selection of LabCorp as its preferred provider for central lab services could be bad news for rival Icon according to industry observers.
CRO PPD (Pharmaceutical Product Development) is bolstering its bioassay and bioanalytical services in both the US and Brazil, respectively, in preparation for more niche biologic and biosimilar developments.
Some of largest pharmaceutical, biotech and CRO (contract research organizations) companies are beginning preparations for a summit in May to focus on how to manage quality in the outsourcing of clinical trials.
ACRO (Association of Contract Research Organizations) is calling on the FDA to clarify draft guidance attempting to mitigate the possible pitfalls in transitioning to electronic source data for clinical investigations.
Canada-based CRO Nordion paid $22.5 million last week to settle a lawsuit by Dr. Reddy’s Laboratories claiming Nordion breached its lab services agreement.
The PRACS Institute has filed for bankruptcy after closing down its US and Canadian research sites, but the question of whether unpaid trial participants will receive payment for their work is still up in the air.
